• Iovance Biotherapeutics granted inducement stock options covering 93,340 shares to 13 new non-executive employees on May 21, 2026.
• The options carry an exercise price of $3.7 per share, set at the stock’s closing price on the grant date.
• Vesting runs over three years, with one-third vesting on the first anniversary of the employee’s start date.
• The remaining shares vest in eight quarterly installments over the following two years, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605221715PRIMZONEFULLFEED9725506) on May 22, 2026, and is solely responsible for the information contained therein.